Pharmacological Enhancement of Integrated Stress Response Confers Protection in Calcific Aortic Valve Disease. [PDF]
Wang L +8 more
europepmc +1 more source
Corrigendum to "Extracellular matrix remodeling in calcific aortic valve disease: Localized enrichment of type III collagen and LTBP-4" [Matrix Biol Plus 30 (2026) 100194]. [PDF]
Kemmochi R +10 more
europepmc +1 more source
Extracellular Vesicles in Calcific Aortic Valve Disease: From Biomarkers to Drug Delivery Applications. [PDF]
Cook-Calvete A +4 more
europepmc +1 more source
Hormonal and Sex-Specific Regulation of Key Players in Fibro-Calcific Aortic Valve Disease. [PDF]
Neussl K +6 more
europepmc +1 more source
Non-rheumatic calcific aortic valve disease in China: findings from the Global Burden of Disease study 2021. [PDF]
Tian H +5 more
europepmc +1 more source
Significance of APOB/APOA1 Ratio in the Prediction of Calcific Aortic Valve Disease. [PDF]
Wang Y +10 more
europepmc +1 more source
IGF1-mediated mesenchymal-endothelial transition as a potential regulatory target in calcific aortic valve disease. [PDF]
Li B +6 more
europepmc +1 more source
Single-nucleus and machine-learning integration identifies HLA-DRA and FTL as immune-metabolic axes and traditional Chinese medicine-targetable hubs in calcific aortic valve disease. [PDF]
Zhao Q +6 more
europepmc +1 more source
Construction of a Three-Dimensional Calcific Aortic Valve Disease Model Using Human iPSC-Derived Valvular Interstitial Cells. [PDF]
Guo R, Qi Z, Qiu P, Mizrak D, Yang B.
europepmc +1 more source
Oxidative low-density lipoprotein and shear induced calcification within a calcific aortic valve disease-on-a-chip platform. [PDF]
Mendoza-Seale M +3 more
europepmc +1 more source

